AKRO logo

Akero Therapeutics, Inc. (AKRO) return on equity

annual ROE:

-39.22%-4.00%(-11.36%)
December 31, 2024

Summary

  • As of today (September 16, 2025), AKRO annual return on equity is -39.22%, with the most recent change of -4.00% (-11.36%) on December 31, 2024.
  • During the last 3 years, AKRO annual ROE has risen by +7.89% (+16.75%).
  • AKRO annual ROE is now -11.36% below its all-time high of -35.22%, reached on December 31, 2023.

Performance

AKRO ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAKROprofitability metrics

quarterly ROE:

-32.30%-0.35%(-1.10%)
June 30, 2025

Summary

  • As of today (September 16, 2025), AKRO quarterly return on equity is -32.30%, with the most recent change of -0.35% (-1.10%) on June 30, 2025.
  • Over the past year, AKRO quarterly ROE has dropped by -2.09% (-6.92%).
  • AKRO quarterly ROE is now -17.50% below its all-time high of -27.49%, reached on September 30, 2023.

Performance

AKRO quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAKROprofitability metrics

ROE Formula

ROE =  Net Income
Shareholders Equity
✕ 100%

AKRO ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-11.4%-6.9%
3 y3 years+16.8%+48.3%
5 y5 years+8.8%+28.9%

AKRO ROE Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-11.4%+16.8%-17.5%+48.3%
5 y5-year-11.4%+16.8%-17.5%+48.3%
alltimeall time-11.4%+96.3%-17.5%+99.3%

AKRO ROE History

DateAnnualQuarterly
Jun 2025
-
-32.30%(+1.1%)
Mar 2025
-
-31.95%(-7.0%)
Dec 2024
-39.22%(+11.4%)
-34.36%(+1.4%)
Sep 2024
-
-33.88%(+12.1%)
Jun 2024
-
-30.21%(-2.7%)
Mar 2024
-
-31.04%(-3.2%)
Dec 2023
-35.22%(-22.1%)
-32.05%(+16.6%)
Sep 2023
-
-27.49%(-17.1%)
Jun 2023
-
-33.17%(-24.6%)
Mar 2023
-
-43.98%(-11.0%)
Dec 2022
-45.20%(-4.1%)
-49.39%(-18.1%)
Sep 2022
-
-60.33%(-3.3%)
Jun 2022
-
-62.41%(+9.5%)
Mar 2022
-
-56.97%(+23.5%)
Dec 2021
-47.11%
-46.12%(+13.8%)
Sep 2021
-
-40.52%(-5.0%)
DateAnnualQuarterly
Jun 2021
-
-42.66%(+4.9%)
Mar 2021
-
-40.67%(-8.0%)
Dec 2020
-40.89%(-4.9%)
-44.21%(+6.0%)
Sep 2020
-
-41.71%(-8.1%)
Jun 2020
-
-45.41%(+11.7%)
Mar 2020
-
-40.65%(+6.8%)
Dec 2019
-43.00%(-80.2%)
-38.05%(-52.6%)
Sep 2019
-
-80.33%(-4.8%)
Jun 2019
-
-84.41%(-29.6%)
Mar 2019
-
-119.96%(+9.8%)
Dec 2018
-217.19%(-79.3%)
-109.23%(-97.7%)
Sep 2018
-
-4767.66%(+115.7%)
Jun 2018
-
-2210.78%(+897.8%)
Mar 2018
-
-221.56%(+77.2%)
Dec 2017
-1046.79%
-
Dec 2017
-
-125.00%

FAQ

  • What is Akero Therapeutics, Inc. annual return on equity?
  • What is the all time high annual ROE for Akero Therapeutics, Inc.?
  • What is Akero Therapeutics, Inc. annual ROE year-on-year change?
  • What is Akero Therapeutics, Inc. quarterly return on equity?
  • What is the all time high quarterly ROE for Akero Therapeutics, Inc.?
  • What is Akero Therapeutics, Inc. quarterly ROE year-on-year change?

What is Akero Therapeutics, Inc. annual return on equity?

The current annual ROE of AKRO is -39.22%

What is the all time high annual ROE for Akero Therapeutics, Inc.?

Akero Therapeutics, Inc. all-time high annual return on equity is -35.22%

What is Akero Therapeutics, Inc. annual ROE year-on-year change?

Over the past year, AKRO annual return on equity has changed by -4.00% (-11.36%)

What is Akero Therapeutics, Inc. quarterly return on equity?

The current quarterly ROE of AKRO is -32.30%

What is the all time high quarterly ROE for Akero Therapeutics, Inc.?

Akero Therapeutics, Inc. all-time high quarterly return on equity is -27.49%

What is Akero Therapeutics, Inc. quarterly ROE year-on-year change?

Over the past year, AKRO quarterly return on equity has changed by -2.09% (-6.92%)
On this page